Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
It also does not keep the fat away
Memorize this and you can calculate any dose at any concentration without looking at a chart
The Deciding Factor: Bioavailability Lets be honest, this is crucial
In June 2025, the European Medicines Agency (EMA) formally concluded that semaglutide-containing medications, including Ozempic, Wegovy, and Rybelsus, may cause rare but serious cases of NAION
For people who use one of the two new GLP-1s, semaglutide (Wegovy) or tirzepatide (Zepbound) to lose weight, the results can vary from person to person
100% fees at risk* 0% GLP-1 for weight loss trend guarantee 8% bodyweight reduction, with or without GLP-1 medications More than just marketing claims, validated weight loss results Years of nutrition-first care, medication management, and GLP-1 deprescription when clinically appropriate Learn about our approach Weight loss without drugs View our outcomes Sustained weight loss a year after GLP-1 deprescription See the results How it works Easy implementation via PBM integrations enables guardrails without rebate impact Navigate members to Virtas effective care via our PBM integrations and member communications Educate on the benefits of Nutrition Therapy and guide each member to the right care with or without GLP-1s Adapt nutrition and behavioral care to each member based on lifestyle, metabolism, and continuous health data Maximize success for those on GLP-1s with provider-led effective titration, side-effect support, and engagement monitoringno wasted spend on off-label prescriptions or ineffective anti-obesity medications
